Association of SLC22A4/5 polymorphisms with steroid responsiveness of inflammatory bowel disease in Japan

Diseases of the Colon and Rectum

Volumn 51, Issue 5, 2008, Pages 598-603

  Nakahara, Seiya ^a   Arimura, Yoshiaki ^a   Saito, Katsuhiko ^a   Goto, Akira ^a   Motoya, Satoshi ^b   Shinomura, Yasuhisa ^a   Miyamoto, Atsushi ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Sapporo Kosei General Hospital   (Japan)

Author keywords

Glucocorticoid; Haplotype; Inflammatory bowel disease; Organic cation transporter; Single nucleotide polymorphisms; SLC22A4 A5

Indexed keywords

CORTICOSTEROID; FATTY ACID TRANSPORTER 4; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; DRUG RESPONSE; ENTERITIS; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; STEROID THERAPY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ALGORITHMS; BAYES THEOREM; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INFLAMMATORY BOWEL DISEASES; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROIDS;

EID: 43049085116     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-008-9208-5     Document Type: Article

References (28)

1. Hampe J, Schreiber S, Shaw SH, et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999;64:808-16.
2. Ho GT, Chiam P, Drummond H, Loane J, Arnott IDR, Satsangi J. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006;24:319-30.
3. Rioux JD, Silverberg MS, Daly MJ, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000;66:1863-70.
4. Tein I. Carnitine transport: pathophysiology and metabolism of known molecular defects. J Inherit Metab Dis 2003;26:147-69.
5. Hediger MA, Romero MF, Peng J-B, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins Induction. Pflugers Arch 2004;447:465-8.
6. Burckhardt G, Wolff NA. Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol 2000;278:F853-66.
7. Rioux JD, Daly MJ, Silverberg MS, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn's disease. Nat Genet 2001;29:223-8.
8. Tokuhiro S, Yamada R, Chang X, et al. An intronic SNP in a RUNX1 binding sites of SLC22A4, encoding an organic cation transpoter, is associated with rheumatoid arthritis. Nat Genet 2003;35:341-8.
9. Kuwahara M, Ikari K, Momohara S, et al. Failure to confirm association between SLC22A4 polymorphism and rheumatoid arthritis in a Japanese population. Arthritis Rheum 2005;52:2947-8.
10. Ho P, Bruce IN, Silman A, et al. Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum 2005;52:3596-602.
11. Butt C, Sun S, Greenwood C, Gladman D, Rahman P. Lack of association of SLC22A4, SLC22A5, SLC9A3R1 and RUNX1 variants in psoriatic arthritis. Rheumatology 2005;44:820-1.
12. Peltekova VD, Wintle RF, Rubbin LA, et al. Functional variants of OTCN cation transporter genes are associated with Crohn disease. Nat Genet 2004;36:471-5.
13. Newman B, Gu X, Wintle R, et al. A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 2005;128:260-9.
14. Yabuuchi H, Tamai I, Nezu J, et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 1999;289:768-73.
15. Ohashi R, Tamai I, Nezu J, et al. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 2001;59:358-66.
16. Urcelay E, Mendoza JL, Martínez A, et al. IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab. World J Gastroenterol 2005;11:1187-92.
17. Saito K, Miyake S, Moriya H, et al. Detection of the four sequence variations of MDR1 gene using TaqMan MGB probe based real-time PCR and haplotype analysis in healthy Japanese subjects. Clin Biochem 2003;36:511-8.
18. Liu K, Muse SV. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005;21:2128-9.
19. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
20. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-9.
21. Saito K, Moriya H, Sawaguchi T, et al. Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects. Clin Biochem 2006;39:303-8.
22. Yamazaki K, Takazoe M, Tanaka T, et al. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J Hum Genet 2004;49:664-8.
23. Tosa M, Negoro K, Kinouchi Y, et al. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease. Scand J Gastroenterol 2006;41:48-53.
24. Lee JE, Choi JH, Lee JH, Lee MG. Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis. Mutat Res 2005;573:195-204.
25. Farrell RJ, Kelleher D. Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol 2003;178:339-46.
26. Alesci S, De Martino MU, Mirani M, et al. L-carnitine: a nutritional modulator of glucocorticoid receptor functions. FASEB J 2003;17:1553-5.
27. Manoli I, De Martino MU, Kino T, Alesci S. Modulatory effects of L-carnitine on glucocorticoid receptor activity. Ann N Y Acad Sci 2004;1033:147-57.
28. Alesci S, De Martino MU, Kino T, Ilias I. L-carnitine is a modulator of the glucocorticoid receptor alpha. Ann N Y Acad Sci 2004;1024:147-52.